Recalls for Codman Neuro

Trufill n-BCA Liquid Embolic System by Codman Neuro: Recall - Incorrect Instructions For Use
01/22/2014 Medical Recall

Incorrectly mixed product can result in the liquid mixture solidifying too slowly and could result in significant impact to the patient, including neurological deficits, pulmonary emboli and possibly death.

  • Company:
    Codman Neuro
FDA Classifies Worldwide Voluntary Correction Notice on TRUFILL® n-BCA Liquid Embolic System as Class I Recall
01/22/2014 Food Recall

Codman Neuro announced today that the U.S. Food and Drug Administration (FDA) has classified the recently initiated medical device correction notice related to the TRUFILL® n-BCA Liquid Embolic System as a Class I recall.

  • Company:
    Codman Neuro
  • Problem
    Incorrect Statement In The Package Instructions For Use